Cargando…

Could a Multi-Marker and Machine Learning Approach Help Stratify Patients with Heart Failure?

Half of the patients with heart failure (HF) have preserved ejection fraction (HFpEF). To date, there are no specific markers to distinguish this subgroup. The main objective of this work was to stratify HF patients using current biochemical markers coupled with clinical data. The cohort study inclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lotierzo, Manuela, Bruno, Romain, Finan-Marchi, Amanda, Huet, Fabien, Kalmanovich, Eran, Rodrigues, Glaucy, Dupuy, Anne-Marie, Adda, Jérôme, Piquemal, David, Richard, Sylvain, Cristol, Jean-Paul, Roubille, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538712/
https://www.ncbi.nlm.nih.gov/pubmed/34684033
http://dx.doi.org/10.3390/medicina57100996
_version_ 1784588572579332096
author Lotierzo, Manuela
Bruno, Romain
Finan-Marchi, Amanda
Huet, Fabien
Kalmanovich, Eran
Rodrigues, Glaucy
Dupuy, Anne-Marie
Adda, Jérôme
Piquemal, David
Richard, Sylvain
Cristol, Jean-Paul
Roubille, François
author_facet Lotierzo, Manuela
Bruno, Romain
Finan-Marchi, Amanda
Huet, Fabien
Kalmanovich, Eran
Rodrigues, Glaucy
Dupuy, Anne-Marie
Adda, Jérôme
Piquemal, David
Richard, Sylvain
Cristol, Jean-Paul
Roubille, François
author_sort Lotierzo, Manuela
collection PubMed
description Half of the patients with heart failure (HF) have preserved ejection fraction (HFpEF). To date, there are no specific markers to distinguish this subgroup. The main objective of this work was to stratify HF patients using current biochemical markers coupled with clinical data. The cohort study included HFpEF (n = 24) and heart failure with reduced ejection fraction (HFrEF) (n = 34) patients as usually considered in clinical practice based on cardiac imaging (EF ≥ 50% for HFpEF; EF < 50% for HFrEF). Routine blood tests consisted of measuring biomarkers of renal and heart functions, inflammation, and iron metabolism. A multi-test approach and analysis of peripheral blood samples aimed to establish a computerized Machine Learning strategy to provide a blood signature to distinguish HFpEF and HFrEF. Based on logistic regression, demographic characteristics and clinical biomarkers showed no statistical significance to differentiate the HFpEF and HFrEF patient subgroups. Hence a multivariate factorial discriminant analysis, performed blindly using the data set, allowed us to stratify the two HF groups. Consequently, a Machine Learning (ML) strategy was developed using the same variables in a genetic algorithm approach. ML provided very encouraging explorative results when considering the small size of the samples applied. The accuracy and the sensitivity were high for both validation and test groups (69% and 100%, 64% and 75%, respectively). Sensitivity was 100% for the validation and 75% for the test group, whereas specificity was 44% and 55% for the validation and test groups because of the small number of samples. Lastly, the precision was acceptable, with 58% in the validation and 60% in the test group. Combining biochemical and clinical markers is an excellent entry to develop a computer classification tool to diagnose HFpEF. This translational approach is a springboard for improving new personalized treatment methods and identifying “high-yield” populations for clinical trials.
format Online
Article
Text
id pubmed-8538712
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85387122021-10-24 Could a Multi-Marker and Machine Learning Approach Help Stratify Patients with Heart Failure? Lotierzo, Manuela Bruno, Romain Finan-Marchi, Amanda Huet, Fabien Kalmanovich, Eran Rodrigues, Glaucy Dupuy, Anne-Marie Adda, Jérôme Piquemal, David Richard, Sylvain Cristol, Jean-Paul Roubille, François Medicina (Kaunas) Brief Report Half of the patients with heart failure (HF) have preserved ejection fraction (HFpEF). To date, there are no specific markers to distinguish this subgroup. The main objective of this work was to stratify HF patients using current biochemical markers coupled with clinical data. The cohort study included HFpEF (n = 24) and heart failure with reduced ejection fraction (HFrEF) (n = 34) patients as usually considered in clinical practice based on cardiac imaging (EF ≥ 50% for HFpEF; EF < 50% for HFrEF). Routine blood tests consisted of measuring biomarkers of renal and heart functions, inflammation, and iron metabolism. A multi-test approach and analysis of peripheral blood samples aimed to establish a computerized Machine Learning strategy to provide a blood signature to distinguish HFpEF and HFrEF. Based on logistic regression, demographic characteristics and clinical biomarkers showed no statistical significance to differentiate the HFpEF and HFrEF patient subgroups. Hence a multivariate factorial discriminant analysis, performed blindly using the data set, allowed us to stratify the two HF groups. Consequently, a Machine Learning (ML) strategy was developed using the same variables in a genetic algorithm approach. ML provided very encouraging explorative results when considering the small size of the samples applied. The accuracy and the sensitivity were high for both validation and test groups (69% and 100%, 64% and 75%, respectively). Sensitivity was 100% for the validation and 75% for the test group, whereas specificity was 44% and 55% for the validation and test groups because of the small number of samples. Lastly, the precision was acceptable, with 58% in the validation and 60% in the test group. Combining biochemical and clinical markers is an excellent entry to develop a computer classification tool to diagnose HFpEF. This translational approach is a springboard for improving new personalized treatment methods and identifying “high-yield” populations for clinical trials. MDPI 2021-09-22 /pmc/articles/PMC8538712/ /pubmed/34684033 http://dx.doi.org/10.3390/medicina57100996 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Brief Report
Lotierzo, Manuela
Bruno, Romain
Finan-Marchi, Amanda
Huet, Fabien
Kalmanovich, Eran
Rodrigues, Glaucy
Dupuy, Anne-Marie
Adda, Jérôme
Piquemal, David
Richard, Sylvain
Cristol, Jean-Paul
Roubille, François
Could a Multi-Marker and Machine Learning Approach Help Stratify Patients with Heart Failure?
title Could a Multi-Marker and Machine Learning Approach Help Stratify Patients with Heart Failure?
title_full Could a Multi-Marker and Machine Learning Approach Help Stratify Patients with Heart Failure?
title_fullStr Could a Multi-Marker and Machine Learning Approach Help Stratify Patients with Heart Failure?
title_full_unstemmed Could a Multi-Marker and Machine Learning Approach Help Stratify Patients with Heart Failure?
title_short Could a Multi-Marker and Machine Learning Approach Help Stratify Patients with Heart Failure?
title_sort could a multi-marker and machine learning approach help stratify patients with heart failure?
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538712/
https://www.ncbi.nlm.nih.gov/pubmed/34684033
http://dx.doi.org/10.3390/medicina57100996
work_keys_str_mv AT lotierzomanuela couldamultimarkerandmachinelearningapproachhelpstratifypatientswithheartfailure
AT brunoromain couldamultimarkerandmachinelearningapproachhelpstratifypatientswithheartfailure
AT finanmarchiamanda couldamultimarkerandmachinelearningapproachhelpstratifypatientswithheartfailure
AT huetfabien couldamultimarkerandmachinelearningapproachhelpstratifypatientswithheartfailure
AT kalmanovicheran couldamultimarkerandmachinelearningapproachhelpstratifypatientswithheartfailure
AT rodriguesglaucy couldamultimarkerandmachinelearningapproachhelpstratifypatientswithheartfailure
AT dupuyannemarie couldamultimarkerandmachinelearningapproachhelpstratifypatientswithheartfailure
AT addajerome couldamultimarkerandmachinelearningapproachhelpstratifypatientswithheartfailure
AT piquemaldavid couldamultimarkerandmachinelearningapproachhelpstratifypatientswithheartfailure
AT richardsylvain couldamultimarkerandmachinelearningapproachhelpstratifypatientswithheartfailure
AT cristoljeanpaul couldamultimarkerandmachinelearningapproachhelpstratifypatientswithheartfailure
AT roubillefrancois couldamultimarkerandmachinelearningapproachhelpstratifypatientswithheartfailure